Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- Check4 days agoChange DetectedA banner announces NIH website updates and links to transition FAQs, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check10 days agoChange DetectedThe site footer revision marker changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal HTML header and a Home link. This indicates that access to the requested resource is blocked.SummaryDifference0.5%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error screen, replacing the expected study record details with a standard error page and site chrome.SummaryDifference18%

- Check60 days agoChange DetectedAdded a funding annotation: 2015 ( U.S. NIH Grant/Contract ) near the study identifiers. Updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.